# Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy

> **NCT00497250** · PHASE1 · UNKNOWN · sponsor: **Fudan University** · enrollment: 32 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Gefitinib
- **DEVICE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00497250
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-07
- **Primary completion:** 2009-03
- **Final completion:** 2009-10
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2008-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497250, "Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00497250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*